PARKINSON DISEASE Is GDNF beneficial in Parkinson disease?

被引：18

作者：

Hoffer, Barry J. ^{[1
]}

Harvey, Brandon K. ^{[1
]}

机构：

[1] Natl Inst Drug Abuse, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA

来源：

NATURE REVIEWS NEUROLOGY | 2011年 / 7卷 / 11期

关键词：

NEUROTROPHIC FACTOR; ALPHA-SYNUCLEIN; EXPRESSION; INFUSION; NEURONS;

D O I：

10.1038/nrneurol.2011.149

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

[No abstract available]

引用

收藏

页码：600 / 602

页数：4

相关论文

共 11 条

[1]

Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease:: A real-time PCR study [J].

Backman, Cristina M. ;

Shan, Lufei ;

Zhang, Ya Jun ;

Hoffer, Barry J. ;

Leonard, Sherry ;

Troncoso, Juan C. ;

Vonsatel, Paul ;

Tomac, Andreas C. .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 252 (1-2) :160-166

[2]

Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease [J].

Bellucci, Arianna ;

Navarria, Laura ;

Zaltieri, Michela ;

Falarti, Elisa ;

Bodei, Serena ;

Sigala, Sandra ;

Battistin, Leontino ;

Spillantini, MariaGrazia ;

Missale, Cristina ;

Spano, PierFranco .

JOURNAL OF NEUROCHEMISTRY, 2011, 116 (04) :588-605

[3]

GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease [J].

Decressac, Mickael ;

Ulusoy, Ayse ;

Mattsson, Bengt ;

Georgievska, Biljana ;

Romero-Ramos, Marina ;

Kirik, Deniz ;

Bjorklund, Anders .

BRAIN, 2011, 134 :2302-2311

[4]

Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys [J].

Eberling, Jamie L. ;

Kells, Adrian P. ;

Pivirotto, Philip ;

Beyer, Janine ;

Bringas, John ;

Federoff, Howard J. ;

Forsayeth, John ;

Bankiewicz, Krystof S. .

HUMAN GENE THERAPY, 2009, 20 (05) :511-518

[5]

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease [J].

Gill, SS ;

Patel, NK ;

Hotton, GR ;

O'Sullivan, K ;

McCarter, R ;

Bunnage, M ;

Brooks, DJ ;

Svendsen, CN ;

Heywood, P .

NATURE MEDICINE, 2003, 9 (05) :589-595

[6]

GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR AUGMENTS MIDBRAIN DOPAMINERGIC CIRCUITS IN-VIVO [J].

HUDSON, J ;

GRANHOLM, AC ;

GERHARDT, GA ;

HENRY, MA ;

HOFFMAN, A ;

BIDDLE, P ;

LEELA, NS ;

MACKERLOVA, L ;

LILE, JD ;

COLLINS, F ;

HOFFER, BJ .

BRAIN RESEARCH BULLETIN, 1995, 36 (05) :425-432

[7]

Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO

[8]

2-Q

[9]

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease [J].

Lang, AE ;

Gill, S ;

Patel, NK ;

Lozano, A ;

Nutt, JG ;

Penn, R ;

Brooks, DJ ;

Hotton, G ;

Moro, E ;

Heywood, P ;

Brodsky, MA ;

Burchiel, K ;

Kelly, P ;

Dalvi, A ;

Scott, B ;

Stacy, M ;

Turner, D ;

Wooten, VGF ;

Elias, WJ ;

Laws, ER ;

Dhawan, V ;

Stoessl, AJ ;

Matcham, J ;

Coffey, RJ ;

Traub, M .

ANNALS OF NEUROLOGY, 2006, 59 (03) :459-466

[10]

PERIPHERAL EXPRESSION AND BIOLOGICAL-ACTIVITIES OF GDNF, A NEW NEUROTROPHIC FACTOR FOR AVIAN AND MAMMALIAN PERIPHERAL NEURONS [J].

TRUPP, M ;

RYDEN, M ;

JORNVALL, H ;

FUNAKOSHI, H ;

TIMMUSK, T ;

ARENAS, E ;

IBANEZ, CF .

JOURNAL OF CELL BIOLOGY, 1995, 130 (01) :137-148